Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Revenue (2023 - 2025)

Historic Revenue for Inhibrx Biosciences (INBX) over the last 3 years, with Q2 2025 value amounting to $1.3 million.

  • Inhibrx Biosciences' Revenue rose 120000.0% to $1.3 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year increase of 7984.68%. This contributed to the annual value of $200000.0 for FY2024, which is 8888.89% down from last year.
  • According to the latest figures from Q2 2025, Inhibrx Biosciences' Revenue is $1.3 million, which was up 120000.0% from -$2.7 million recorded in Q1 2025.
  • Inhibrx Biosciences' Revenue's 5-year high stood at $1.6 million during Q4 2023, with a 5-year trough of -$8.1 million in Q1 2024.
  • For the 3-year period, Inhibrx Biosciences' Revenue averaged around -$942000.0, with its median value being $100000.0 (2024).
  • Its Revenue has fluctuated over the past 5 years, first tumbled by 9388.0% in 2024, then surged by 120000.0% in 2025.
  • Quarter analysis of 3 years shows Inhibrx Biosciences' Revenue stood at $1.6 million in 2023, then tumbled by 93.88% to $100000.0 in 2024, then surged by 1200.0% to $1.3 million in 2025.
  • Its Revenue stands at $1.3 million for Q2 2025, versus -$2.7 million for Q1 2025 and $100000.0 for Q4 2024.